The Prevalence and Trends of Contrast-Induced Nephropathy Among Hospitalized Patients Undergoing Cardiac
Charles O Poluyi1, Omar A Oudit1, Jamal C Perry2
1Internal Medicine, Brookdale University Hospital Medical Center, Brooklyn, USA.
Insights
Contrast-induced nephropathy (CIN) is increasingly common in patients receiving cardiac resynchronization therapy (CRT), leading to worse outcomes. Early risk stratification and nephroprotective strategies are crucial for this population.
Area of Science:
- Cardiology
- Nephrology
- Health Services Research
Background:
- Contrast-induced nephropathy (CIN) is a known risk with iodinated contrast agents used in cardiac procedures.
- Cardiac resynchronization therapy (CRT) requires contrast, posing a risk for CIN in heart failure patients.
- The prevalence and outcomes of CIN in CRT recipients are not well understood.
Purpose of the Study:
- To determine the annual prevalence and trends of CIN in patients undergoing CRT.
- To evaluate the association of CIN with clinical outcomes and healthcare utilization in CRT patients.
Main Methods:
- Retrospective cohort study using the Nationwide Readmissions Database (NRD) from 2016-2020.
- Identified adult patients undergoing CRT or CRT-D implantation using ICD-10 codes.
- Analyzed CIN prevalence, 30-day readmission, mortality, metabolic acidosis, hyperkalemia, and CRRT use, with multivariable logistic regression for temporal trends.
Main Results:
- CIN prevalence increased from 20.61% in 2016 to 26.40% in 2020 (p < 0.001).
- CIN was linked to higher 30-day readmissions, longer hospital stays, and increased costs.
- Incidence of metabolic acidosis and CRRT use also rose significantly; overall mortality was higher in CIN patients but showed no significant time trend.
Conclusions:
- CIN is a growing complication in CRT patients, associated with adverse outcomes and increased healthcare utilization.
- Findings highlight the need for standardized nephroprotective strategies, including contrast dose reduction and early risk assessment.
- Mitigating renal complications in this high-risk group is essential.
Introduction:
Contrast-induced nephropathy (CIN) is a significant complication following the use of iodinated contrast agents during cardiac procedures. Cardiac resynchronization therapy (CRT), increasingly used in heart failure management, requires contrast administration, putting patients at risk for CIN. However, the prevalence and outcomes of CIN in CRT recipients remain underexplored.
Methods:
We conducted a retrospective cohort study using the Nationwide Readmissions Database (NRD) from 2016 to 2020. Adult patients undergoing CRT or CRT-D implantation were identified using International Classification of Diseases, 10th edition (ICD-10) codes. The primary outcome was the annual prevalence of CIN. Secondary outcomes included 30-day hospital readmission, mortality, metabolic acidosis, hyperkalemia, and continuous renal replacement therapy (CRRT). Multivariable logistic regression assessed temporal trends, adjusting for patient demographics and comorbidities.
Results:
Among 42,545 patients undergoing CRT, CIN prevalence increased from 20.61% in 2016 to 26.40% in 2020 (p < 0.001). CIN was associated with significantly higher 30-day readmission rates, longer hospital stays (mean length of stay (LOS): 7.64 vs. 4.36 days in non-elective cases), and higher hospitalization costs. The incidence of metabolic acidosis rose from 13.73% to 18.51% (p < 0.001), and CRRT use increased from 3.30% to 5.11% (p = 0.03). While overall mortality was higher among CIN patients (2.84% vs. 0.53%), no significant trend in mortality was observed over time (p = 0.352).
Conclusion:
CIN is an increasingly prevalent complication in patients undergoing CRT and is associated with worse clinical outcomes and higher healthcare utilization. These findings underscore the need for implementing standardized nephroprotective strategies, including contrast minimization protocols and early risk stratification, to mitigate renal complications in this high-risk population.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Imaging Studies for Cardiovascular System V: CT
Continuous Renal Replacement Therapy
Cardiac Catheterization IV: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure III: Clinical Manifestations


